Results 251 to 260 of about 113,809 (305)

GLP‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels

Microcirculation, Volume 33, Issue 5, July 2026.
ABSTRACT Objectives Recent clinical studies have suggested that glucagon‐like peptide‐1 receptor (GLP‐1R) agonists may be effective therapies to treat or reduce the risk of developing secondary lymphedema. In this study, we aimed to (1) determine if GLP‐1Rs are present in the lymphatic vasculature and characterize their expression, and (2) assess the ...
Mary E. Schulz, Victoria L. Akerstrom, Joseph H. Dayan, Jorge A. Castorena‐Gonzalez   +3 more
wiley   +1 more source

Factors Associated with Low-Dose Tamoxifen Use among Women with Atypical Hyperplasia or Lobular or Ductal Carcinoma In Situ. [PDF]

Cancer Prev Res (Phila)
Deshmukh MS, Kyle MH, Zeiger PJ, Ro V, McGuinness JE, Michel A, Eli R, Kukafka R, Crew KD.   +8 more
europepmc   +1 more source

Serious mental illness and cancer: A call to action for equitable care

CA: A Cancer Journal for Clinicians, Volume 76, Issue 4, July/August 2026.
Abstract Cancer advances are not distributed equitably among many segments of the population. Specifically, individuals with serious mental illness (SMI) face compounded disparities in cancer detection, treatment, and survival. SMI, characterized by conditions such as schizophrenia, bipolar disorder, and severe major depression, is associated with ...
Daniel McFarland, Cristiane Bergerot, Pernille Bidstrup, Miri Cohen, Paul D’Alton, Shahrzhad Zamani, Louise Mullen, Michelle Riba, Luigi Grassi, Kelly Irwin   +9 more
wiley   +1 more source

UNC45B Reduction With Aging: A Myofiber-Intrinsic Promoting Factor for Sarcopenia. [PDF]

Aging Cell
Mishima T, Nagamune T, Tada S, Watanabe D, Tokuda N, Yamada T, Hashimoto-Hachiya A, Higo-Yamamoto S, Kido K, Nagaoka N, Ikedo A, Imai Y, Fujita R, Mizuno S, Takahashi S, Oishi K, Ato S, Ogasawara R.   +17 more
europepmc   +1 more source

(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective. [PDF]

Degener Neurol Neuromuscul Dis
Remmel HL, Hammer SS, Blackburn SM, Quay SC.   +3 more
europepmc   +1 more source

Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis. [PDF]

Front Oncol
Wang R, Ji J, Liu L.
europepmc   +1 more source

RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons. [PDF]

Neurotherapeutics
Yan K, Ma R, Wang B, Feng X, Li X, Meng X, Shang H, Kidd BM, Swanson MS, Hu H, Tao YX.   +10 more
europepmc   +1 more source

Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells. [PDF]

PLoS One
Rujimongkon K, Adchariyasakulchai P, Boonyaratsewee C, Horpratraporn K, Ketchart W.   +4 more
europepmc   +1 more source

Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity. [PDF]

Cancer Res Commun
Wang Q, Zhang W, Chen J, Stenson KT, Parsai S, Parthasarathy PB, Liu CF, Garrett T, Lin J, Hou A, Shimpi RA, Gu E, Yin M, Shannon L, Johnson S, Willard BB, Rodriguez ER, Androjna C, Moudgil R, Sun Y, Yu JS, Nguyen C, Alban TJ, Chan TA, Prasad SVN, Tang WHW, Lin J, Zhao J.   +27 more
europepmc   +1 more source